Primary cervical screening with high risk human papillomavirus testing: observational study

Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience

(2018) Olga Veijalainen et al.   CYTOPATHOLOGY

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60

(2017) Helena Lamin et al.   BMJ Open

Human papillomavirus test with cytology triage in organized screening for cervical cancer

(2016) Olga Veijalainen et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program

(2016) Tiziano Maggino et al.   BRITISH JOURNAL OF CANCER

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

(2016) Alejandra Castanon et al.   JOURNAL OF MEDICAL SCREENING

Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme

(2016) Emily McBride et al.   BMJ Open

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

(2016) Maaike G Dijkstra et al.   BMJ-British Medical Journal

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

(2016) Maaike G Dijkstra et al.   BMJ-British Medical Journal

HPV primary cervical screening: time for a change

(2015) H. C. Kitchener   CYTOPATHOLOGY

Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial

(2015) Christine Bergeron et al.   JNCI-Journal of the National Cancer Institute

Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial

(2015) Christine Bergeron et al.   JNCI-Journal of the National Cancer Institute

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening

(2014) HC Kitchener et al.   HEALTH TECHNOLOGY ASSESSMENT

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds

(2014) Henry C Kitchener et al.   HEALTH TECHNOLOGY ASSESSMENT

Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women

(2014) Annarosa Del Mistro et al.   JOURNAL OF MEDICAL SCREENING

Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme

(2014) L Pasquale et al.   JOURNAL OF MEDICAL SCREENING

Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study

(2013) M Zorzi et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers

(2012) A. Castanon et al.   CYTOPATHOLOGY

High-risk HPV testing on self-sampledversusclinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening

(2012) Peter J.F. Snijders et al.   INTERNATIONAL JOURNAL OF CANCER

Pilot study will assess whether HPV test should replace smears to screen for cervical cancer

(2012) J. Wise   BMJ-British Medical Journal

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial

(2011) Henry C. Kitchener et al.   EUROPEAN JOURNAL OF CANCER

Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30

(2011) Matejka Rebolj et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Screening for Cervical Cancer with the Human Papillomavirus Test in an Area of Central Italy with No Previous Active Cytological Screening Programme

(2010) Massimo Confortini et al.   JOURNAL OF MEDICAL SCREENING

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY